Eversens

Eversens is a forward-thinking company that focuses on creating non-invasive clinical diagnostic systems. These systems work by detecting biomarkers in a patient's breath, which can provide valuable information about their health. Founded in 2015, Eversens boasts a highly skilled team of engineers with over 20 years of international experience in research and development (R&D) projects. The company collaborates closely with hospitals and doctors in Spain and the USA, particularly those specializing in allergology (the study of allergies) and asthma treatment.

Eversens operates in the healthcare market, specifically targeting the medical diagnostics sector. Their primary clients include hospitals, clinics, and healthcare providers who need reliable and accurate diagnostic tools. By offering equipment that can detect exhaled biomarkers, Eversens aims to improve the diagnosis and management of various health conditions, particularly respiratory issues like asthma.

The business model of Eversens revolves around the design, development, and manufacturing of these diagnostic systems. They generate revenue by selling their equipment to healthcare institutions and possibly through service agreements for maintenance and updates. Their mission is to enhance health and welfare by providing highly reliable and accurate diagnostic tools.

In summary, Eversens is a specialized healthcare company dedicated to improving clinical diagnostics through innovative, non-invasive technology. They serve hospitals and healthcare providers in the allergology and asthma treatment fields, primarily in Spain and the USA. Their business model focuses on the sale and maintenance of their diagnostic equipment, contributing to better health outcomes for patients.

Keywords: healthcare, diagnostics, non-invasive, biomarkers, asthma, allergology, hospitals, clinics, R&D, innovation.